Article
Clinical characteristics and survival outcome of early-stage, high-grade, serous tubo-ovarian carcinoma according to BRCA mutational status.
Gynecologic oncology - 1 Aug 2024
Marchetti Claudia, Ataseven Beyhan, Perrone Anna M, Cassani Chiara, Fruscio Robert, Sassu Carolina M, Apostol Adriana I, Harter Philipp, De Iaco Pierandrea, Camnasio Cristina Angela, Moubarak Malak, Giannarelli Diana, Scambia Giovanni, Fagotti Anna
Abstract excerpt
OBJECTIVE: To investigate the role of BRCA1/2 mutations in early ovarian cancer (eOC) (International Federation of Gynecology and Obstetrics FIGO 2014 stage I-II), and its impact on prognosis after relapse. METHODS: In this multicenter retrospective study, clinical and survival data from high-grade serous (HGS)-eOC patients at presentation and recurrence were compared according to BRCA status: BRCA-mutated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
